Mahmoud M. Mubarek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mahmoud M. Mubarek has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Othman
Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt
2 shared publications Rehab A. Lotfy
Department of Medicinal and Aromatic plants, Desert Research Center, Matariya, Cairo, Egypt
2 shared publicationsAhmed R. Hassan
Department of Medicinal and Aromatic plants, Desert Research Center, Matariya, Cairo, Egypt
1 shared publication- Amany Ameen Sleem
Pharmacology Department, National Research Centre, Dokki, Giza, Egypt
1 shared publication Fahd M. Abdelkarem
Department of Agro-environmental Sciences, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University
1 shared publication- Fahd M. Abdelkarem
Al-Azhar University
1 shared publication
Latest Publications
- 23 August 2024
- Published by ACG Publications in Records of Natural Products
- Vol. 18 (4) , 393-404
Isolation of New Secondary Metabolites from Kedrostis gijef and Evaluation of Their α-Glucosidase Inhibitory Activity
Four new polyoxygenated cucurbitane triterpene glycosides named kedrojiftene A-D (4-7), were isolated via different chromatographic techniques along with three phenolic compounds (1-3) from the crude extract of Kedrostis gijef. The isolated compounds were elucidated based on 1D, 2D-NMR spectroscopic analyses, HRESIMS and comparison with the related metabolites in literature. In bioassay, the α-glucosidase inhibitory assay for the isolated compounds was carried out and compounds (1-3) showed significant inhibitory activities.
- 23 August 2024
- Published by ACG Publications in Records of Natural Products
- Vol. 18 (4) , 393-404
Isolation of New Secondary Metabolites from Kedrostis gijef and Evaluation of Their α-Glucosidase Inhibitory Activity
Four new polyoxygenated cucurbitane triterpene glycosides named kedrojiftene A-D (4-7), were isolated via different chromatographic techniques along with three phenolic compounds (1-3) from the crude extract of Kedrostis gijef. The isolated compounds were elucidated based on 1D, 2D-NMR spectroscopic analyses, HRESIMS and comparison with the related metabolites in literature. In bioassay, the α-glucosidase inhibitory assay for the isolated compounds was carried out and compounds (1-3) showed significant inhibitory activities.
- 17 June 2024
- Published by Taylor & Francis in Natural Product Research
- Vol. 39 (21) , 6099-6107
Isolation of two new cucurbitane-type triterpenoids from Kedrostis gijef
Two new cucurbitane-type triterpenoids (2,3), together with two known compounds (1,4), were isolated from the aerial parts of Kedrostis gijef. The structure of all compounds was elucidated based on NMR, HRESIMS analyses, and by comparison with the literature. Additionally, the cytotoxic activity against HeLa, Caco-2, and SH-SY5Y cell lines was determined using MTT colorimetric assay.
- 17 June 2024
- Published by Taylor & Francis in Natural Product Research
- Vol. 39 (21) , 6099-6107
Isolation of two new cucurbitane-type triterpenoids from Kedrostis gijef
Two new cucurbitane-type triterpenoids (2,3), together with two known compounds (1,4), were isolated from the aerial parts of Kedrostis gijef. The structure of all compounds was elucidated based on NMR, HRESIMS analyses, and by comparison with the literature. Additionally, the cytotoxic activity against HeLa, Caco-2, and SH-SY5Y cell lines was determined using MTT colorimetric assay.
- 25 June 2021
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 20 (2) , 1129-1135
In vivo antidiabetic potential of standardized Gymnocarpos decandrus Forssk. Extract
Background Gymnocarpos decandrus (Caryophyllaceae) is a well-known wild plant used as a food for grazing animals. Recently it showed potent antidiabetic potential beside its established anti-inflammatory, analgesic and diuretic activities. G. decandrus antidiabetic potential was reported through in-vitro models and resulted in promising α-amylase, α-glucosidase and antiviral Coxsackie B4 inhibitory activities; however no in-vivo studies were conducted. Purpose This study aims to examine Gymnocarpos decandrus ethanol extract (GDEE) safety and to evaluate its in vivo antidiabetic potential. Method Adult albino rats were injected intraperitoneally with alloxan to induce diabetes mellitus and the glucose level was measured after two and four weeks against metformin as a standard drug. Additionally, GDEE characterization and standardization were carried out. Results GDEE LD50 was up to 5.8 mg/kg and exhibited significant antidiabetic activity 77.17% comparable to the standard drug metformin. Its total phenolics, and flavonoids amounted 127.2 ± 0.23 and 85.5 ± 0.21 mg/g respectively. Vitexin was used as a marker compound for GDEE (140.70 mg/100 gm). Conclusion This study represents the sole in vivo scientific validation of G. decandrus recently documented in vitro antidiabetic potential.
- 25 June 2021
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 20 (2) , 1129-1135
In vivo antidiabetic potential of standardized Gymnocarpos decandrus Forssk. Extract
Background Gymnocarpos decandrus (Caryophyllaceae) is a well-known wild plant used as a food for grazing animals. Recently it showed potent antidiabetic potential beside its established anti-inflammatory, analgesic and diuretic activities. G. decandrus antidiabetic potential was reported through in-vitro models and resulted in promising α-amylase, α-glucosidase and antiviral Coxsackie B4 inhibitory activities; however no in-vivo studies were conducted. Purpose This study aims to examine Gymnocarpos decandrus ethanol extract (GDEE) safety and to evaluate its in vivo antidiabetic potential. Method Adult albino rats were injected intraperitoneally with alloxan to induce diabetes mellitus and the glucose level was measured after two and four weeks against metformin as a standard drug. Additionally, GDEE characterization and standardization were carried out. Results GDEE LD50 was up to 5.8 mg/kg and exhibited significant antidiabetic activity 77.17% comparable to the standard drug metformin. Its total phenolics, and flavonoids amounted 127.2 ± 0.23 and 85.5 ± 0.21 mg/g respectively. Vitexin was used as a marker compound for GDEE (140.70 mg/100 gm). Conclusion This study represents the sole in vivo scientific validation of G. decandrus recently documented in vitro antidiabetic potential.
- 13 August 2020
- Published by Taylor & Francis in Natural Product Research
- Vol. 35 (24) , 5954-5959
Validation of Antidiabetic Potential of Gymnocarpos decandrus Forssk
Gymnocarpos decandrus Forssk. is a well-known grazing wild plant. This study targets scientific validation of its claimed antidiabetic activity and exploring its bioactive metabolites. Chromatographic purification of G. decandrus ethanol extract (GDEE) allowed isolation of vitexin (C1), protocatechuic acid (C2) and quercetin (C3). HPLC-PDA-MS/MS enabled identification of nineteen metabolites; 13 flavonoids, 5 saponins, and 1 phenolic acid in G. decandrus and four in the genus Gymnocarpos for the first time. The antidiabetic potential was evaluated via testing the Coxsackie B4 virus and α-glucosidase inhibitory potentials. C3 exhibited its potent antiviral activity through blocking of the virus attachment (96.28%, SI 4.41) and virus inactivation before adsorption (91.47%, SI 4.78). GDEE and C1–C3 showed dose dependent α-glucosidase inhibitory activity with IC50 of 733.9, 293.3, 118.1 and 69.1 µg/mL, respectively. Our study represents the sole complete map for G. decandrus secondary metabolites and presents it as promising drug for diabetes management.
- 13 August 2020
- Published by Taylor & Francis in Natural Product Research
- Vol. 35 (24) , 5954-5959
Validation of Antidiabetic Potential of Gymnocarpos decandrus Forssk
Gymnocarpos decandrus Forssk. is a well-known grazing wild plant. This study targets scientific validation of its claimed antidiabetic activity and exploring its bioactive metabolites. Chromatographic purification of G. decandrus ethanol extract (GDEE) allowed isolation of vitexin (C1), protocatechuic acid (C2) and quercetin (C3). HPLC-PDA-MS/MS enabled identification of nineteen metabolites; 13 flavonoids, 5 saponins, and 1 phenolic acid in G. decandrus and four in the genus Gymnocarpos for the first time. The antidiabetic potential was evaluated via testing the Coxsackie B4 virus and α-glucosidase inhibitory potentials. C3 exhibited its potent antiviral activity through blocking of the virus attachment (96.28%, SI 4.41) and virus inactivation before adsorption (91.47%, SI 4.78). GDEE and C1–C3 showed dose dependent α-glucosidase inhibitory activity with IC50 of 733.9, 293.3, 118.1 and 69.1 µg/mL, respectively. Our study represents the sole complete map for G. decandrus secondary metabolites and presents it as promising drug for diabetes management.